Skip to main content

Amturnide FDA Approval History

FDA Approved: Yes (Discontinued) (First approved December 21, 2010)
Brand name: Amturnide
Generic name: aliskiren, amlodipine and hydrochlorothiazide
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure

Marketing Status: Discontinued

Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is a direct renin inhibitor, calcium channel blocker and diuretic combination for the treatment of high blood pressure.

Development timeline for Amturnide

Dec 22, 2010Approval Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.